Literature DB >> 4302266

Carbohydrate metabolism in cancer cells and the molecular correlation concept.

G Weber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4302266     DOI: 10.1007/bf00602650

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


× No keyword cloud information.
  46 in total

1.  COMPARATIVE BIOCHEMISTRY HEPATOMAS. IV. ISOTOPE STUDIES OF GLUCOSE AND FRUCTOSE METABOLISM IN LIVER TUMORS OF DIFFERENT GROWTH RATES.

Authors:  M J SWEENEY; J ASHMORE; H P MORRIS; G WEBER
Journal:  Cancer Res       Date:  1963-08       Impact factor: 12.701

2.  PATTERNS OF GLYCOLYTIC ENZYMES IN RAT LIVER AND HEPATOMA.

Authors:  C E SHONK; H P MORRIS; G E BOXER
Journal:  Cancer Res       Date:  1965-06       Impact factor: 12.701

3.  Comparative biochemistry of hepatomas. II. Isotope studies of carbohydrate metabolism in Morris hepatoma 5123.

Authors:  G WEBER; H P MORRIS; W C LOVE; J ASHMORE
Journal:  Cancer Res       Date:  1961-11       Impact factor: 12.701

4.  Energy pathways of hepatoma No. 5123.

Authors:  A C AISENBERG; H P MORRIS
Journal:  Nature       Date:  1961-09-23       Impact factor: 49.962

5.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

6.  Glucose metabolism in a low-glycolysing tumour, the Morris Hepatoma 5123.

Authors:  Y C LIN; J C ELWOOD; A ROSADO; H P MORRIS; S WEINHOUSE
Journal:  Nature       Date:  1962-07-14       Impact factor: 49.962

7.  Studies on respiration and glycolysis in transplanted hepatic tumors of the rat.

Authors:  C Lo; V J Cristofalo; H P Morris; S Weinhouse
Journal:  Cancer Res       Date:  1968-01       Impact factor: 12.701

8.  Beta-hydroxybutyrate dehydrogenase activity in liver and liver tumors.

Authors:  K Ohe; H P Morris; S Weinhouse
Journal:  Cancer Res       Date:  1967-08       Impact factor: 12.701

9.  Regulatory pattern of liver carbohydrate metabolizing enzymes: insulin as inducer of key glycolytic enzymes.

Authors:  G Weber; M A Lea; E A Fisher; N B Stamm
Journal:  Enzymol Biol Clin (Basel)       Date:  1966

10.  Metabolic adaptations in rat hepatomas. I. The effect of dietary protein on some inducible enzymes in liver and hepatoma 5123.

Authors:  H C PITOT; V R POTTER; H P MORRIS
Journal:  Cancer Res       Date:  1961-09       Impact factor: 12.701

View more
  8 in total

Review 1.  Use of positron emission tomography in anticancer drug development.

Authors:  Eric O Aboagye; Patricia M Price
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

2.  Pyruvate kinase inhibited by L-cysteine as a marker of tumorigenic human urothelial cell lines.

Authors:  M Gumińska; M B Stachurska; B Christensen; V Tromholt; J Kieler; C Radzikowski; D Duś
Journal:  Experientia       Date:  1989-06-15

3.  Glutathione content of human skin carcinomas.

Authors:  A Engin
Journal:  Arch Dermatol Res       Date:  1976-11-26       Impact factor: 3.017

4.  Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate.

Authors:  He N Xu; Stephen Kadlececk; Harrilla Profka; Jerry D Glickson; Rahim Rizi; Lin Z Li
Journal:  Acad Radiol       Date:  2014-02       Impact factor: 3.173

Review 5.  A critical review of the role of M2PYK in the Warburg effect.

Authors:  Robert A Harris; Aron W Fenton
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-01-29       Impact factor: 10.680

6.  Activity of antitumor drugs against African trypanosomes.

Authors:  K E Kinnamon; E A Steck; D S Rane
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

7.  The use of deoxyfluoro-D-glucopyranoses and related compounds in a study of yeast hexokinase specificity.

Authors:  E M Bessell; A B Foster; J H Westwood
Journal:  Biochem J       Date:  1972-06       Impact factor: 3.857

Review 8.  The cancer cell's "power plants" as promising therapeutic targets: an overview.

Authors:  Peter L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 3.853

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.